Skip to content

Improving Cancer Survival and Reducing Treatment Variations With Protocols for Emergency Care

Improving Cancer Survival and Reducing Treatment Variations With Protocols for Emergency Care (ICARE)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04673890
Acronym
ICARE
Enrollment
152
Registered
2020-12-17
Start date
2020-08-06
Completion date
2022-01-15
Last updated
2022-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

Significant challenges and gaps remain in navigating transitions between acute care and outpatient care for many cancer survivors. This study underscores 1) implementation of Emergency Department (ED) risk-stratified treatments protocols that standardize patient care and would allow for rapid re-assessment and access to specialist care with well-coordinated cancer care plans, and 2) the significant numbers of minority cancer survivors seeking episodic care in the ED that are at increased risk of not receiving recommended post cancer treatment surveillance.

Detailed description

The over-arching goal of this study is to develop a portable model for ED cancer treatment guidelines and management using evidence based protocols in a population at high risk for poor cancer -related outcomes by identifying & overcoming specific barriers to enhanced survivorship. Based on the demographics of ED population (currently, 70% racial/ethnic minorities), the majority of participants will be underrepresented (African-American and Hispanic) and low-income individuals. The investigators propose a feasibility study of 150 patients in the ED over a 1 year period. The specific aims are: Aim 1: Evaluate the effectiveness of ED Risk-Stratified, Evidence-Based Treatment protocols on the primary outcome of ED utilization rates and subsequent acute inpatient admissions at 6 -months post-intervention. Aim 2: Evaluate the effectiveness of an ED-based Cancer Patient Navigator on the secondary outcomes of patient engagement and primary care engagement at 6 -months post-intervention. Aim 3: Examine barriers and facilitators to compliance for cancer survivorship recommendations that occur in an ED setting at 6-months post intervention.

Interventions

None listed

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
University of Illinois at Chicago
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Cancer survivor (has had cancer in their lifetime, and is currently disease-free) * Verbal fluency in English or Spanish * Age 18-75 years

Exclusion criteria

* Unable to verbalize comprehension of study or impaired decision making (e.g., dementia) * Plans to move from Chicago area within the next year

Design outcomes

Primary

MeasureTime frameDescription
ED utilization rate6 months from study entryEmergency department utilization over 6 month period
Mortality30 days from study entryMortality due to deep vein thrombosis/pulmonary embolism, due to sepsis, and overall mortality

Secondary

MeasureTime frameDescription
Admission and Readmission rate6 months from study entryall cause, and related to sepsis

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026